Pharma

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

November 20, 2024

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

November 13, 2024

Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer

October 31, 2024

New England Biolabs Leases 28,000 SF

December 7, 2020

Immunology biotech firm to relocate from Cambridge to Woburn

November 18, 2021

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

October 28, 2022

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform

Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases

Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint

Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA

Most Read

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

Pardis Sabeti Appointed to Gordon and Betty Moore Foundation Board of Trustees

Northwell Health to host inaugural Aging Revolution Summit

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

EDITOR PICKS

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer

POPULAR POSTS

New England Biolabs Leases 28,000 SF

Immunology biotech firm to relocate from Cambridge to Woburn

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

POPULAR CATEGORY

ABOUT US

FOLLOW US